Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About Cell Therapy Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment. Technavio?s analysts forecast the global cell therapy market to grow at a CAGR of 23.27% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global cell therapy market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? Dendreon ? Mesoblast ? Vericel Other prominent vendors ? AlloCure ? Amorcyte ? Anterogen ? Antibe Therapeutics ? Astellas Pharma ? Athersys ? Avita Medical ? AxoGen ? Bellicum Pharmaceuticals ? BioCardia ? BIOCELLULAR THERAPIES ? Biogen Idec ? Bio-Tissue ? BIOTIME ? BioTissue Technologies ? BrainStorm Cell Therapeutics ? Bluebird Bio ? Bone Therapeutics ? Caladrius ? Capricor Therapeutics ? CellBioMed ? Celgene ? Cell Medica ? CellPraxis ? CellSeed ? Cell Therapy ? Celyad ? CESCA THERAPEUTICS ? CRC for Cell Therapy Manufacturing ? CryoLife ? Cynata Therapeutics ? Cytori Therapeutics ? DiscGenics ? Fate Therapeutics ? Fibrocell Science ? Forticell Bioscience ? Fortress Biotech ? Gamida Cell ? GlaxoSmithKline ? Healthpoint ? Histogen ? Histogenics ? Holostem Terapie Avanzate ? Humacyte ? Immunocellular Therapeutics ? Integra Life Sciences ? Intercytex ? iSTO Technologies ? Janssen Pharma ? Juno Therapeutics ? Juventas Therapeutics ? Kensey Nash ? Kite Pharma ? Kiadis Pharma ? LifeNet Health ? Living Cell Technologies ? Lonza ? MaxCyte ? MEDIPOST ? Nanofiber Solutions ? Nanotope ? Neuralstem ? Newlink Genetics ? Northwest Biotherapeutics ? NovaRx ? Ocata Therapeutics ? Opexa Therapeutics ? Orbsen Therapeutics ? Pfizer ? Pharmicell ? Pluristem Therapeutics ? Prima BioMed ? Q Therapeutics ? Regenerexx ? Regeneus ? Regenerys ? Regience ? Regrow ? RepliCel ? ReproCELL ? ReNeuron ? RenovaCare ? RESSTORE ? RhinoCyte ? Rohto Pharmaceutical ? SanBio ? Sangamo BioSciences ? Shanghai Sunway Biotech ? Shire Regenerative Medicine ? StemCells ? STEMPEUTICS RESEARCH ? Synergistic Technologies ? t2cure ? Takara Bio ? tella ? Tengion ? TissueGene ? Tessa Therapeutics ? Txcell ? VentriNova ? ViaCyte ? VistaGen Therapeutics ? SDRMI and Xcelthera Market driver ? Increase in prevalence of chronic diseases ? For a full, detailed list, view our report Market challenge ? High cost of clinical trials and cell therapy doses ? For a full, detailed list, view our report Market trend ? Proliferation of strategic alliances and royalty payments ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction ? Overview ? Government funding and support PART 05: Market landscape ? Overview ? Market size and forecast ? PART 06: Pipeline portfolio ? Overview ? Regulatory framework for cell therapy products ? Pipeline analysis ? Five forces analysis PART 07: Segmentation by application ? Overview ? Dermatology ? Musculoskeletal ? Ocular ? Cardiovascular PART 08: Segmentation by end-user ? Hospitals and clinics ? ASCs ? Regenerative medicine centers PART 09: Segmentation by geography ? Overview ? Americas ? EMEA ? APAC PART 10: Decision framework PART 11: Drivers and challenges ? Market drivers ? Market challenges PART 12: Market trends ? Focus on business strategies ? Proliferation of strategic alliances and royalty payments ? Geographic expansion of gene therapy PART 13: Vendor landscape ? Competitive landscape ? PART 14: Key vendor analysis ? Dendreon ? Mesoblast ? Vericel ? Other prominent vendors PART 15: Appendix ? List of abbreviations ? List of Exhibits Exhibit 01: Types of stem cells used in cell therapy products: Overview Exhibit 02: Collaborative funding for cell therapy-based research in US Exhibit 03: Ethical challenges associated with stem cell research Exhibit 04: Stem cell research policies in countries in Americas Exhibit 05: Stem cell research policies in countries in EMEA Exhibit 06: Stem cell research policies in countries in APAC Exhibit 07: Global cell therapy market 2016-2021 ($ billions) Exhibit 08: Global cell therapy market: Overview Exhibit 09: Cell therapy pipeline for CVDs Exhibit 10: Cell therapy pipelines for CNS, orthopedic, and ocular disorders Exhibit 11: Cell therapy pipeline for dermatology and diabetes Exhibit 12: Cell therapy pipeline for oncology Exhibit 13: Five forces analysis Exhibit 14: Global stem cell therapy market: Segmentation by application 2016 (% share) Exhibit 15: Cell therapy for dermatology: Overview Exhibit 16: Cell therapy for burns and diabetic wound treatment: Opportunity analysis Exhibit 17: Cell therapy products for dermatology pipeline Exhibit 18: Cell therapy for musculoskeletal: Overview Exhibit 19: Cell therapy for occupational and sports-related injuries: Overview Exhibit 20: Cell therapy for musculoskeletal pipeline Exhibit 21: Cell therapy for ocular: Overview Exhibit 22: Cell therapy for ocular pipeline Exhibit 23: Cell therapy for cardiovascular: Overview Exhibit 24: Cell therapy for cardiovascular: Overview Exhibit 25: Global cell therapy market: Overview of segmentation by end-user Exhibit 26: Funding and partnership for cell therapy product development Exhibit 27: Hospital collaborations for cell therapy Exhibit 28: Global cell therapy market: Segmentation by geography 2016 and 2021 ($ billions) Exhibit 29: Cell therapy market in Americas: Overview Exhibit 30: Cell therapy market in Americas 2016-2021 ($ billions) Exhibit 31: Cell therapy market in Americas: Overview by country Exhibit 32: SBIR and STTR programs Exhibit 33: Cell therapy market in US: Overview Exhibit 34: Cell therapy market in EMEA: Overview Exhibit 35: Cell therapy market in EMEA 2016-2021 ($ billions) Exhibit 36: Cell therapy market in EMEA: Overview by country Exhibit 37: Cell therapy market in UK Exhibit 38: Cell therapy market in APAC 2016-2021 ($ billions) Exhibit 39: Cell therapy market in APAC: Overview by country Exhibit 40: Cell therapy market in Japan: Overview Exhibit 41: Chronic diseases in US and Europe Exhibit 42: Fall and hip fracture in US 2016 Exhibit 43: Number of road injuries in UK 2015 Exhibit 44: Regulatory challenges associated with regenerative medicine Exhibit 45: Key business strategies adopted by companies Exhibit 46: Major strategic alliances Exhibit 47: Competitive structure analysis Exhibit 48: Competitive landscape Exhibit 49: Strategies for companies Exhibit 50: Key recommendations for new entrants Exhibit 51: Dendreon: Key highlights Exhibit 52: Dendreon: Strength assessment Exhibit 53: Dendreon: Strategy assessment Exhibit 54: Dendreon: Opportunity assessment Exhibit 55: Mesoblast: Key highlights Exhibit 56: Mesoblast: Strength assessment Exhibit 57: Mesoblast: Strategy assessment Exhibit 58: Mesoblast: Opportunity assessment Exhibit 59: Vericel: Key highlights Exhibit 60: Vericel: Strength assessment Exhibit 61: Vericel: Strategy assessment Exhibit 62: Vericel: Opportunity assessment
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?